Solventum (SOLV) Competitors $73.43 +1.48 (+2.05%) As of 10:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, BLCO, IRTC, and SLNOShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. Solventum vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies Soleno Therapeutics GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment. Does the media prefer GEHC or SOLV? In the previous week, GE HealthCare Technologies had 3 more articles in the media than Solventum. MarketBeat recorded 24 mentions for GE HealthCare Technologies and 21 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 1.20 beat Solventum's score of 1.14 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 19 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 11 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GEHC or SOLV more profitable? GE HealthCare Technologies has a net margin of 11.22% compared to Solventum's net margin of 4.55%. Solventum's return on equity of 31.01% beat GE HealthCare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies11.22% 23.93% 6.29% Solventum 4.55%31.01%6.53% Do analysts rate GEHC or SOLV? GE HealthCare Technologies presently has a consensus price target of $88.55, suggesting a potential upside of 24.01%. Solventum has a consensus price target of $85.25, suggesting a potential upside of 15.07%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27 Which has stronger valuation & earnings, GEHC or SOLV? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.97B1.63$1.99B$4.8814.63Solventum$8.25B1.55$478M$2.1634.30 Do insiders & institutionals have more ownership in GEHC or SOLV? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.1% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, GEHC or SOLV? GE HealthCare Technologies has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. SummaryGE HealthCare Technologies beats Solventum on 13 of the 16 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$12.86B$7.13B$5.42B$20.67BDividend YieldN/A2.83%3.99%3.66%P/E Ratio34.4162.8629.9028.65Price / Sales1.5526.91372.1768.82Price / Cash7.3026.5935.9423.59Price / Book4.3217.548.104.32Net Income$478M$239.96M$3.26B$995.66M7 Day Performance3.28%1.08%0.65%1.91%1 Month Performance-1.29%-3.72%2.43%-0.54%1 Year Performance26.30%22.84%27.70%14.76% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.4575 of 5 stars$73.43+2.1%$85.25+16.1%+28.8%$12.72B$8.25B34.0322,000News CoveragePositive NewsEarnings ReportAnalyst ForecastGEHCGE HealthCare Technologies3.8587 of 5 stars$77.74+0.2%$88.55+13.9%-10.4%$35.60B$19.67B16.3753,000Positive NewsPHGKoninklijke Philips3.5033 of 5 stars$25.65-1.9%N/A-7.4%$24.70B$19.50B59.6566,678ZBHZimmer Biomet4.6627 of 5 stars$95.94-1.7%$111.39+16.1%-7.1%$18.98B$7.70B21.2317,000Positive NewsEarnings ReportAnalyst ForecastGap UpSNNSmith & Nephew SNATS2.4249 of 5 stars$31.19-1.5%$28.00-10.2%+21.3%$13.66B$5.81B14.4417,349Dividend CutPENPenumbra4.8595 of 5 stars$229.90-1.4%$305.07+32.7%+46.7%$8.90B$1.19B216.894,500STVNStevanato Group2.1493 of 5 stars€25.77-2.8%N/A+23.3%€7.80B€1.19B50.535,521News CoverageAnalyst RevisionGKOSGlaukos4 of 5 stars$94.80+0.5%$134.67+42.1%-24.1%$5.42B$383.48M-40.00780BLCOBausch + Lomb3.1058 of 5 stars$14.47+1.0%$15.45+6.8%-10.0%$5.12B$4.79B-14.0513,500IRTCiRhythm Technologies1.9586 of 5 stars$137.11+2.2%$137.30+0.1%+135.0%$4.38B$618.59M-43.672,000Insider TradeSLNOSoleno Therapeutics4.5817 of 5 stars$85.25-1.4%$108.70+27.5%+79.0%$4.30BN/A-18.4530News CoverageEarnings ReportAnalyst ForecastGap Up Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives IRTC Alternatives SLNO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
